Analysts See This Pharma Stock Surging 60%; Eyes Fresh Entry
Drug stock Innoviva has used recent declines as an opportunity to build a bullish base. Analysts see hearty price gains ahead.
Source: Investor's Business Daily
Drug stock Innoviva has used recent declines as an opportunity to build a bullish base. Analysts see hearty price gains ahead.
